Startup profile · funding coverage

Function Oncology

Function Oncology is an Andreessen Horowitz (a16z) portfolio company currently tracked as part of our hot a16z coverage set.

Stage

See coverage

Status

private

Coverage

full

Why Function Oncology is interesting

Function Oncology appears on a16z’s public investment list. We include it because a16z-backed companies are disproportionately “on fire” for follow-on capital, hiring, and category creation — useful for founders mapping competitors and investors mapping active theses (AI, American Dynamism, crypto, bio, fintech).

Key facts

Series A (2023): $28M co-led by a16z and Section 32 with Casdin Capital (BusinessWire)
Co-investors: no additional institutional investors disclosed in public sources reviewed 2026-07-24

Investors in our directory

Funds linked from Function Oncology's profile — open a fund page for stage focus and related deal articles.

Andreessen Horowitz

Industries

Enterprise SaaS

Industry hub pages are rolling out from our fund-derived baseline taxonomy.

FAQs about Function Oncology

Funding context and why this company shows up in venture coverage.

Function Oncology is listed among Andreessen Horowitz (a16z) investments on a16z’s public investment list.

We track a16z-backed companies that are strategically relevant for founders and investors following AI, American Dynamism, crypto, bio, and enterprise software.

All startups Funding news

Last updated: 2026-07-24